CCK-8 and xenograft assay results showed that disruption of this module in SRC-activated TNBC cells could potentially inhibit the hyperproliferation in vitro (Fig. S8E–F) and the tumor overgrowth in vivo (Fig. 5G–J). The gene discussed is SRC; the disease is neoplasm.